• AM251 in Neuroimmune Modulation: Expanding CB1 Antagonist Ho

  2026-05-20

  Discover how AM251, a potent CB1 receptor antagonist, is redefining cannabinoid receptor research by bridging neuroimmune signaling and metabolic study. This article uniquely explores AM251's dual roles in neuronal and immune contexts, offering in-depth protocol insights and practical guidance for advanced neuroscience research.

• CDC42 Regulates Intestinal Stem Cell Fate via YAP-mTOR Signa

  2026-05-20

  This study uncovers how CDC42-mediated apical-basal polarity regulates the transition from intestinal stem cells to transit amplifying cells via a Hippo-YAP-EGF-mTOR signaling axis. The findings clarify the distinct molecular mechanisms maintaining epithelial homeostasis and provide new directions for gastrointestinal stem cell research.

• Tigecycline in the Modern Lab: Advanced Antimicrobial Modeli

  2026-05-19

  Explore the role of Tigecycline as a glycylcycline antibiotic in multidrug-resistant bacteria research. This article uniquely focuses on advanced in vitro and in vivo modeling strategies, integrating novel resistance dynamics for translational success.

• Refining In Vitro Drug Response Evaluation in Cancer Researc

  2026-05-19

  Schwartz’s dissertation introduces a crucial distinction between drug-induced growth inhibition and cell death in in vitro cancer models, challenging the prevailing use of amalgamated viability metrics. This nuanced framework enables more accurate interpretation of compound efficacy and improves experimental reproducibility for preclinical oncology research.

• Trichostatin A (TSA): HDAC Inhibition for Precision Oncology

  2026-05-18

  Discover how Trichostatin A (TSA) advances cancer research through potent HDAC inhibition, with new insights from recent in vivo screens and protocol guidance. Explore its unique role in precision oncology and epigenetic regulation.

• Clodronate Liposomes: Optimizing In Vivo Macrophage Depletio

  2026-05-18

  Clodronate Liposomes deliver targeted, reproducible macrophage depletion in vivo, accelerating mechanistic immunology and translational oncology research. This guide unpacks stepwise workflows, troubleshooting strategies, and innovative applications informed by landmark studies and experimental best practices.

• EGTA in Translational Neurocardiac Research: Mechanism to Im

  2026-05-17

  This article provides translational researchers with a mechanistic and strategic guide to deploying EGTA (3,12-bis(carboxymethyl)-6,9-dioxa-3,12-diazatetradecane-1,14-dioic acid, egtazic acid) for precision calcium modulation. Bridging foundational neurophysiology with forward-looking workflow recommendations, we evaluate EGTA—available from APExBIO—for its role in dissecting voltage-dependent calcium channel (VDCC) function, modulating nitric oxide-induced calcium influx, and informing neuroprotection strategies in disease models. Drawing on recent literature, including seminal work on agatoxin-IVA-sensitive channels in cardiac vagal neurons, this piece extends beyond standard product writeups by connecting mechanistic insight with actionable experimental design and translational vision.

• 10 mM dNTP Mixture: Optimizing DNA Synthesis & PCR Results

  2026-05-16

  The 10 mM dNTP (2'-deoxyribonucleoside-5'-triphosphate) mixture streamlines DNA synthesis, ensuring equimolar balance and maximum fidelity across PCR, sequencing, and advanced molecular protocols. This article translates reference-driven insights and best practices into actionable workflows and troubleshooting strategies for high-performance molecular biology.

• Sisomicin in Translational Infection Research: Mechanisms &

  2026-05-15

  This thought-leadership article examines Sisomicin, a potent aminoglycoside antibiotic, through the lens of translational research strategy. It explores mechanistic insights into 30S ribosomal targeting, in vitro and in vivo experimental rigor, resistance dynamics, and the evolving landscape of antibacterial testing. Integrating recent evidence and workflow guidance, the article provides actionable recommendations, highlights APExBIO’s Sisomicin as a research-grade solution, and articulates how strategic use of this antibiotic can accelerate and de-risk infection research.

• 2,2,2-Trichloroethanol: Small Molecule Biochemical for Prote

  2026-05-15

  2,2,2-Trichloroethanol is redefining protein analysis workflows with its high solubility, purity, and adaptability in molecular biology research. Its robust performance as a protein analysis reagent streamlines experimental reliability and troubleshooting, especially in neurobiology and stem cell contexts. Explore how APExBIO’s offering empowers next-generation assay development.

• ALDOB K87 Lactylation Orchestrates Mitochondrial Dynamics in

  2026-05-14

  This study identifies ALDOB K87 lactylation as a pivotal driver of mitochondrial fission and metabolic reprogramming in pulmonary hypertension. The findings reveal a novel lactate–ALDOB–DRP1 axis that mechanistically links metabolic shifts to pathological smooth muscle cell proliferation, suggesting new avenues for targeted intervention in vascular remodeling.

• TAK1-YAP Axis Drives Gastric Cancer Stem Cell Renewal

  2026-05-14

  This study elucidates how TGFβ-activated kinase 1 (TAK1) stabilizes yes-associated protein (YAP), promoting the self-renewal and oncogenicity of gastric cancer stem cells. The mechanistic insights highlight TAK1 as a potential target for disrupting stemness-driven tumor progression and therapy resistance in gastric cancer.

• Light-Inducible RNA-Releasing Proteins Enable Precise Gene T

  2026-05-13

  A recent study introduces a rationally designed light-inducible RNA-releasing protein (LIRP) that allows for spatiotemporal regulation of gene expression at the translational level in vivo. This innovation offers a promising approach for developing safer, more controllable gene therapies for chronic metabolic and retinal diseases.

• BX795: PDK1 Inhibitor Workflows for Immunity and Cancer Rese

  2026-05-13

  BX795 unlocks targeted inhibition of PDK1, TBK1, and IKKε, enabling precise modulation of PI3K/Akt/mTOR and innate immune pathways in cancer and virology models. This guide translates recent mechanistic discoveries into actionable protocols, troubleshooting insights, and advanced cross-domain use-cases for high-impact bench research.

• SIRT1 Regulation of Plk2 Acetylation Controls Centriole Dupl

  2026-05-12

  This study elucidates how SIRT1-mediated deacetylation of Plk2 governs centriole duplication, providing new mechanistic insight into the epigenetic control of centrosome homeostasis. The findings have broad implications for cancer research, where centrosome amplification and cell cycle dysregulation play central roles in tumorigenesis.

16273 records 1/1085 page Next 12345 下5页 Last page